English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/111328
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorCherif, O.-
dc.contributor.authorAllouche, F.-
dc.contributor.authorChabchoub, Fakher-
dc.contributor.authorChioua, Mourad-
dc.contributor.authorSoriano, Elena-
dc.contributor.authorYáñez, Matilde-
dc.contributor.authorCacabelos, Ramón-
dc.contributor.authorRomero, A.-
dc.contributor.authorLópez, M. G.-
dc.contributor.authorMarco-Contelles, José-
dc.date.accessioned2015-02-26T10:13:47Z-
dc.date.available2015-02-26T10:13:47Z-
dc.date.issued2015-
dc.identifierdoi: 10.4155/fmc.14.115-
dc.identifierissn: 1756-8919-
dc.identifiere-issn: 1756-8927-
dc.identifier.citationFuture Medicinal Chemistry 6: 1883-1891 (2015)-
dc.identifier.urihttp://hdl.handle.net/10261/111328-
dc.description.abstractBackground: Owing to the complex nature of Alzheimer's disease, there is a renewed and growing search for multitarget non-toxic tacrines as simple, easily available drugs in order to stop the progress and development of the disease. Results: This paper describes our preliminary results on the synthesis, in vitro biochemical evaluation and molecular modeling of isoxazolotacrines as potential drugs for the treatment of Alzheimer's disease. Novel 3-phenyl-5,6,7,8-tetrahydroisoxazolo[5,4-b]quinolin-4-amine (OC41) is a promising, 31% less toxic than tacrine in HepG2 cells, and selective reversible human butyrylcholinesterase inhibitor (IC50 = 5.08 ± 1.12 μM), also showing good drug-like properties according to the absorption, Distribution, Metabolism, Excretion, Toxicity analysis. Conclusion: A new family of non-hepatotoxic permeable tacrine analogs, showing selective butyrylcholinesterase inhibition, have been discovered for the potential treatment of Alzheimer's disease.-
dc.publisherFuture Science-
dc.rightsclosedAccess-
dc.titleIsoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease-
dc.typeartículo-
dc.identifier.doi10.4155/fmc.14.115-
dc.date.updated2015-02-26T10:13:47Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
Appears in Collections:(IQOG) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.